instruction
stringlengths 30
82
| output
stringlengths 13
790
|
|---|---|
What is the type of genetic variation for RS148327780 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS148327780 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593454066 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593454066 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593454066 SNP. |
In which chromosome is RS1593454066 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593454066 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593454066 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593454066 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593454066 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593454066 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593454066 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593435736 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593435736 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593435736 SNP. |
In which chromosome is RS1593435736 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593435736 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593435736 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593435736 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593435736 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593435736 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593435736 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS746662122 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS746662122 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS746662122 SNP. |
In which chromosome is RS746662122 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS746662122 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS746662122 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS746662122 SNP? | The variation length is 1 base pairs. |
What is the origin for RS746662122 SNP? | The origin is germline. |
What is the type of genetic variation for RS746662122 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS746662122 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1419123438 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1419123438 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1419123438 SNP. |
In which chromosome is RS1419123438 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1419123438 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1419123438 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1419123438 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1419123438 SNP? | The origin is germline. |
What is the type of genetic variation for RS1419123438 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1419123438 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1039235140 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1039235140 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1039235140 SNP. |
In which chromosome is RS1039235140 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1039235140 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1039235140 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1039235140 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1039235140 SNP? | The origin is germline. |
What is the type of genetic variation for RS1039235140 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1039235140 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1411090163 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1411090163 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1411090163 SNP. |
In which chromosome is RS1411090163 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1411090163 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1411090163 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1411090163 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1411090163 SNP? | The origin is germline. |
What is the type of genetic variation for RS1411090163 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1411090163 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1060504826 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1060504826 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1060504826 SNP. |
In which chromosome is RS1060504826 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1060504826 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1060504826 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1060504826 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1060504826 SNP? | The origin is germline. |
What is the type of genetic variation for RS1060504826 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1060504826 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1593531868 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593531868 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593531868 SNP. |
In which chromosome is RS1593531868 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593531868 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593531868 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593531868 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593531868 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593531868 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593531868 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1316896547 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1316896547 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1316896547 SNP. |
In which chromosome is RS1316896547 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1316896547 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1316896547 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1316896547 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1316896547 SNP? | The origin is germline. |
What is the type of genetic variation for RS1316896547 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1316896547 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS201020747 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS201020747 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS201020747 SNP. |
In which chromosome is RS201020747 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS201020747 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS201020747 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS201020747 SNP? | The variation length is 1 base pairs. |
What is the origin for RS201020747 SNP? | The origin is germline. |
What is the type of genetic variation for RS201020747 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS201020747 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1593411999 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593411999 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593411999 SNP. |
In which chromosome is RS1593411999 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1593411999 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1593411999 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1593411999 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1593411999 SNP? | The origin is germline. |
What is the type of genetic variation for RS1593411999 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1593411999 SNP? | The resulting gene consequence is a synonymous variant. |
Which condition is asociated with RS1010049143 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1010049143 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1010049143 SNP. |
In which chromosome is RS1010049143 SNP located? | It is located in the chromosome 13. |
Which methods support the evidence found for the RS1010049143 SNP? | Associated methods are: clinical testing. |
What is the clinical significance of RS1010049143 SNP, is it benign or pathogenic? | It is Likely benign. |
How long is the variation length for RS1010049143 SNP? | The variation length is 1 base pairs. |
What is the origin for RS1010049143 SNP? | The origin is germline. |
What is the type of genetic variation for RS1010049143 SNP? | The variation is a single nucleotide variant. |
What is the genetic molecular consequence for RS1010049143 SNP? | The resulting gene consequence is a intron variant. |
Which condition is asociated with RS1593529908 SNP? | Retinoblastoma is a malignant tumor of the developing retina that occurs in children, usually before age five years. Retinoblastoma develops from cells that have cancer-predisposing variants in both copies of RB1. Retinoblastoma may be unifocal or multifocal. About 60% of affected individuals have unilateral retinoblastoma with a mean age of diagnosis of 24 months; about 40% have bilateral retinoblastoma with a mean age of diagnosis of 15 months. Heritable retinoblastoma is an autosomal dominant susceptibility for retinoblastoma. Individuals with heritable retinoblastoma are also at increased risk of developing non-ocular tumors. The associated SNPedia page is https://www.snpedia.com/index.php/RsRS1593529908 SNP. The NCBI page is https://www.ncbi.nlm.nih.gov/snp/RS1593529908 SNP. |
In which chromosome is RS1593529908 SNP located? | It is located in the chromosome 13. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.